
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
Miray Tonk, Daniel Růžek, Andreas Vilcinskas
Viruses (2021) Vol. 13, Iss. 5, pp. 912-912
Open Access | Times Cited: 32
Miray Tonk, Daniel Růžek, Andreas Vilcinskas
Viruses (2021) Vol. 13, Iss. 5, pp. 912-912
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
dbAMP 2.0: updated resource for antimicrobial peptides with an enhanced scanning method for genomic and proteomic data
Jhih-Hua Jhong, Lantian Yao, Yuxuan Pang, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D460-D470
Open Access | Times Cited: 117
Jhih-Hua Jhong, Lantian Yao, Yuxuan Pang, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D460-D470
Open Access | Times Cited: 117
Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides
Xin Li, Siyao Zuo, Wang Bin, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2675-2675
Open Access | Times Cited: 115
Xin Li, Siyao Zuo, Wang Bin, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2675-2675
Open Access | Times Cited: 115
Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms
Tania Vanzolini, Michela Bruschi, Andrea C. Rinaldi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 545-545
Open Access | Times Cited: 71
Tania Vanzolini, Michela Bruschi, Andrea C. Rinaldi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 545-545
Open Access | Times Cited: 71
DRAVP: A Comprehensive Database of Antiviral Peptides and Proteins
Yanchao Liu, Youzhuo Zhu, Xin Sun, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 820-820
Open Access | Times Cited: 25
Yanchao Liu, Youzhuo Zhu, Xin Sun, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 820-820
Open Access | Times Cited: 25
Lysozyme: A Natural Product with Multiple and Useful Antiviral Properties
Alberta Bergamo, Gianni Sava
Molecules (2024) Vol. 29, Iss. 3, pp. 652-652
Open Access | Times Cited: 16
Alberta Bergamo, Gianni Sava
Molecules (2024) Vol. 29, Iss. 3, pp. 652-652
Open Access | Times Cited: 16
Combating Antimicrobial Resistance by Employing Antimicrobial Peptides: Immunomodulators and Therapeutic Agents against Infectious Diseases
Insha Mehraj, Aflaq Hamid, Ubaid Gani, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 4, pp. 2023-2035
Closed Access | Times Cited: 12
Insha Mehraj, Aflaq Hamid, Ubaid Gani, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 4, pp. 2023-2035
Closed Access | Times Cited: 12
Antimicrobial Peptides Derived from Bacteria: Classification, Sources, and Mechanism of Action against Multidrug-Resistant Bacteria
Raynichka Mihaylova-Garnizova, Slavena Davidova, Yordan Hodzhev, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10788-10788
Open Access | Times Cited: 11
Raynichka Mihaylova-Garnizova, Slavena Davidova, Yordan Hodzhev, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10788-10788
Open Access | Times Cited: 11
Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses
Linda Sukmarini
Molecules (2022) Vol. 27, Iss. 9, pp. 2619-2619
Open Access | Times Cited: 32
Linda Sukmarini
Molecules (2022) Vol. 27, Iss. 9, pp. 2619-2619
Open Access | Times Cited: 32
Antimicrobial peptides: features, applications and the potential use against covid-19
Dalia M. Mabrouk
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 10039-10050
Open Access | Times Cited: 29
Dalia M. Mabrouk
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 10039-10050
Open Access | Times Cited: 29
Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
M. Ghalib Enayathullah, Yash Parekh, Sarena Banu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
M. Ghalib Enayathullah, Yash Parekh, Sarena Banu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Comparative analysis of machine learning-based approaches for identifying therapeutic peptides targeting SARS-CoV-2
Balachandran Manavalan, Shaherin Basith, Gwang Lee
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Balachandran Manavalan, Shaherin Basith, Gwang Lee
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 26
An updated review of functional properties, debittering methods, and applications of soybean functional peptides
Xinjie Hu, Qinqiu Zhang, Qing Zhang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 27, pp. 8823-8838
Closed Access | Times Cited: 19
Xinjie Hu, Qinqiu Zhang, Qing Zhang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 27, pp. 8823-8838
Closed Access | Times Cited: 19
Antiviral Peptides in Antimicrobial Surface Coatings—From Current Techniques to Potential Applications
Mahe Jabeen, Payel Biswas, Md Touhidul Islam, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 640-640
Open Access | Times Cited: 10
Mahe Jabeen, Payel Biswas, Md Touhidul Islam, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 640-640
Open Access | Times Cited: 10
Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions
Iman Owliaee, Mehran Khaledian, Ali Shojaeian, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Iman Owliaee, Mehran Khaledian, Ali Shojaeian, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Molecular modeling and screening of antibacterial peptides for Streptococcus pneumoniae DNA gyrase B using Hpepdock software for the therapy of pneumonia infection
G. Anusha, Deepika Rani
AIP conference proceedings (2025) Vol. 3270, pp. 020088-020088
Closed Access
G. Anusha, Deepika Rani
AIP conference proceedings (2025) Vol. 3270, pp. 020088-020088
Closed Access
Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro
Zainab Jan, Anupriya M. Geethakumari, Kabir H. Biswas, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3665-3671
Open Access | Times Cited: 9
Zainab Jan, Anupriya M. Geethakumari, Kabir H. Biswas, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3665-3671
Open Access | Times Cited: 9
Antimicrobial Peptides Derived from Bacteria: Classification, Sources, and Mechanism of Action against Multidrug-Resistant Bacteria
Raynichka Mihaylova-Garnizova, Slavena Davidova, Yordan Hodzhev, et al.
(2024)
Open Access | Times Cited: 3
Raynichka Mihaylova-Garnizova, Slavena Davidova, Yordan Hodzhev, et al.
(2024)
Open Access | Times Cited: 3
Altered Expression of Antimicrobial Peptides in the Upper Gastrointestinal Tract of Patients with Diabetes Mellitus
Oliver Linn, Bernhard Menges, Frank Lammert, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 754-754
Open Access | Times Cited: 8
Oliver Linn, Bernhard Menges, Frank Lammert, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 754-754
Open Access | Times Cited: 8
Physicochemical and sequence determinants of antiviral peptides
Abhigyan Nath
Biologia Futura (2023) Vol. 74, Iss. 4, pp. 489-506
Closed Access | Times Cited: 4
Abhigyan Nath
Biologia Futura (2023) Vol. 74, Iss. 4, pp. 489-506
Closed Access | Times Cited: 4
In silico screening and evaluation of antiviral peptides as inhibitors against ORF9b protein of SARS-CoV-2
Gaurav Kumar Sharma, Prateek Paul, Ananya Dviwedi, et al.
3 Biotech (2024) Vol. 14, Iss. 9
Closed Access | Times Cited: 1
Gaurav Kumar Sharma, Prateek Paul, Ananya Dviwedi, et al.
3 Biotech (2024) Vol. 14, Iss. 9
Closed Access | Times Cited: 1
Defensins: Therapeutic molecules with potential to treat SARS-CoV-2 infection
Sarena Banu, Ramakrishnan Nagaraj, Mohammed M. Idris
The Indian Journal of Medical Research (2022) Vol. 155, Iss. 1, pp. 83-85
Open Access | Times Cited: 4
Sarena Banu, Ramakrishnan Nagaraj, Mohammed M. Idris
The Indian Journal of Medical Research (2022) Vol. 155, Iss. 1, pp. 83-85
Open Access | Times Cited: 4
Antiviral potential of copper and titanium dioxide nanoparticles against H1N1, Adenovirus 40 and herpes simplex virus type-II
Ahmed A. Hmed, Atef S. El-Gebaly, Ehab E. Refaey, et al.
Inorganic Chemistry Communications (2024), pp. 113605-113605
Closed Access
Ahmed A. Hmed, Atef S. El-Gebaly, Ehab E. Refaey, et al.
Inorganic Chemistry Communications (2024), pp. 113605-113605
Closed Access
Gramicidin S and Melittin - Potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
Mohammed Ghalib, Yash Parekh, Sarena Banu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 2
Mohammed Ghalib, Yash Parekh, Sarena Banu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 2
ENERGIAS LIVRES DE LIGAÇÃO ABSOLUTA DO PEPTÍDEO ANTIVIRAL ATN-161 COM ALVOS PROTEICOS DE SARS-COV-2
RUDIELSON DOS SANTOS SILVA
(2023)
Open Access
RUDIELSON DOS SANTOS SILVA
(2023)
Open Access
Molecular Modeling and Screening of Antiviral peptides for HIV-Glycoprotein (gp41) using Hpepdock software for the therapy of AIDS (Acquired ImmunoDeficiency Syndrome)
G. Anusha, M. Monisha
Cardiometry (2023), Iss. 25, pp. 1702-1710
Open Access
G. Anusha, M. Monisha
Cardiometry (2023), Iss. 25, pp. 1702-1710
Open Access